About the Authors
- Steven A. Saenz
-
Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing
* E-mail: steven.saenz@bms.com (SAS); michael.ellis@bms.com (JME)
Affiliation Immunology, Cardiovascular & Fibrosis, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Andrea Local
-
Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, California, United States of America
- Tiffany Carr
-
Roles Conceptualization, Data curation, Formal analysis, Writing – original draft
Affiliation Immunology, Cardiovascular & Fibrosis, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Arvind Shakya
-
Roles Data curation, Formal analysis
Affiliation Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, California, United States of America
- Shivsmriti Koul
-
Roles Data curation, Formal analysis
Affiliation Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, California, United States of America
- Haiqing Hu
-
Roles Data curation, Formal analysis
Affiliation Preclinical Candidate Optimization, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Lisa Chourb
-
Roles Data curation, Formal analysis
Affiliation Preclinical Candidate Optimization, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Justin Stedman
-
Roles Data curation, Formal analysis
Affiliation Preclinical Candidate Optimization, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Jenna Malley
-
Roles Formal analysis
Current address: Takeda Pharmaceuticals, Cambridge, Massachusetts, United States of America
Affiliation Nonclinical Development, Celgene Corporation, Cambridge, Massachusetts, United States of America
- Laura Akullian D’Agostino
-
Roles Data curation, Formal analysis, Supervision, Visualization, Writing – original draft
Affiliation Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Veerabahu Shanmugasundaram
-
Roles Visualization
Affiliation Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- John Malona
-
Roles Formal analysis
Current address: Jnana Therapeutics, Boston, Massachusetts, United States of America
Affiliation Drug Substance Development, Bristol Myers Squibb, Summit, New Jersey, United States of America
- C. Eric Schwartz
-
Roles Formal analysis, Supervision
Current address: Cedilla Therapeutics, Cambridge, Massachusetts, United States of America
Affiliation Drug Substance Development, Bristol Myers Squibb, Summit, New Jersey, United States of America
- Lisa Beebe
-
Roles Conceptualization, Data curation, Supervision
Affiliation Preclinical Candidate Optimization, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Meghan Clements
-
Roles Conceptualization, Data curation, Formal analysis
Current address: AbbVie, Worcester, Massachusetts, United States of America
Affiliation Nonclinical Development, Celgene Corporation, Cambridge, Massachusetts, United States of America
- Ganesh Rajaraman
-
Roles Supervision
Current address: Novartis Pharmaceuticals, Cambridge, Massachusetts, United States of America
Affiliation Nonclinical Development, Celgene Corporation, Cambridge, Massachusetts, United States of America
- John Cho
-
Roles Supervision
Current address: KSQ Therapeutics, Cambridge, Massachusetts, United States of America
Affiliation Immunology & Inflammation, Celgene Corporation, Cambridge, Massachusetts, United States of America
- Lan Jiang
-
Roles Formal analysis
Affiliation Immunology, Cardiovascular & Fibrosis, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Alex Dubrovskiy
-
Roles Formal analysis
Affiliation Immunology, Cardiovascular & Fibrosis, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Matt Kreilein
-
Roles Formal analysis, Supervision
Affiliation Drug Substance Development, Bristol Myers Squibb, Summit, New Jersey, United States of America
- Roman Shimanovich
-
Roles Formal analysis, Supervision
Affiliation Preclinical Candidate Optimization, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Lawrence G. Hamann
-
Roles Supervision
Current address: Takeda Pharmaceuticals, Cambridge, Massachusetts, United States of America
Affiliation Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
- Laure Escoubet
-
Roles Data curation, Supervision, Writing – original draft
Affiliation Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, California, United States of America
- J. Michael Ellis
-
Roles Conceptualization, Supervision, Writing – original draft
* E-mail: steven.saenz@bms.com (SAS); michael.ellis@bms.com (JME)
Affiliation Small Molecule Drug Discovery, Bristol Myers Squibb, Cambridge, Massachusetts, United States of America
Competing Interests
All authors are either present or former employees of Celgene Corporation and/or Bristol Myers Squibb and own stocks and/or shares of Bristol Myers Squibb. All work for the current study was performed by authors only while employed at Celgene Corporation or Bristol Myers Squibb. Celgene Corporation is a wholly owned subsidiary of Bristol Myers Squibb. The Bristol Myers Squibb was the sole funder for this study and provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. Jenna Malley & Lawrence G. Hamann are currently employed by Takeda Pharmaceuticals. John Malona is currently employed by Jnana Therapeutics. C. Eric Schwartz is currently employed by Cedilla Therapeutics. Meghan Clements is currently employed by AbbVie. Ganesh Rajaraman is currently employed by Novartis Pharmaceuticals. John Cho is currently employed by KSQ Therapeutics. Neither Takeda Pharmaceuticals, Jnana Therapeutics, Cedilla Therapeutics, AbbVie, Novartis Pharmaceuticals or KSQ Therapeutics provided funding to the current work and these affiliations do not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.